Memorial Sloan-Kettering Cancer Center, N.Y., offers 5% taxable bonds

By Sheri Kasprzak

New York, Jan. 9 - The Memorial Sloan-Kettering Cancer Center of New York plans to sell 5% taxable bonds, according to a preliminary official statement. The exact size of the offering has not been determined.

The bonds (Aa2/AA-/AA) will be sold on a negotiated basis with Goldman Sachs & Co. as the senior manager. The co-managers are J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC.

The bonds are due July 1, 2042.

Proceeds will be used to finance capital projects for the cancer center.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.